[HTML][HTML] 2021 clinical practice guidelines for diabetes mellitus in Korea

KY Hur, MK Moon, JS Park, SK Kim… - Diabetes & …, 2021 - synapse.koreamed.org
Abstract The Committee of Clinical Practice Guidelines of the Korean Diabetes Association
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …

Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for …

DS Kyoung, HS Kim - Journal of Lipid and Atherosclerosis, 2021 - pmc.ncbi.nlm.nih.gov
Almost every Korean (97%) is enrolled in the National Health Insurance program, and most
receive medical treatment at least once a year. Data are collected by the Health Insurance …

[HTML][HTML] Diabetes fact sheets in Korea, 2020: an appraisal of current status

CH Jung, JW Son, S Kang, WJ Kim… - Diabetes & …, 2021 - synapse.koreamed.org
Background This study aimed to investigate the recent prevalence, management, and
comorbidities of diabetes among Korean adults aged≥ 30 years by analyzing nationally …

The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study

S Hong, K Han, CY Park - BMC medicine, 2020 - Springer
Abstract Background The triglyceride glucose (TyG) index is an inexpensive clinical
surrogate marker for insulin resistance. However, the relationship between TyG index and …

Epidemiology of cardiovascular disease and its risk factors in Korea

HC Kim - Global health & medicine, 2021 - jstage.jst.go.jp
Cardiovascular disease (CVD) is the leading cause of death and a major contributor to
disability worldwide. Currently, Korea is among countries with the lowest CVD mortality …

[HTML][HTML] The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea

MK Kim, JH Jeon, SW Kim, JS Moon… - Diabetes & …, 2020 - synapse.koreamed.org
Background Coronavirus disease 2019 (COVID-19) is a global pandemic that had affected
more than eight million people worldwide by June 2020. Given the importance of the …

The metabolic score for insulin resistance (METS-IR) as a predictor of incident ischemic heart disease: a longitudinal study among Korean without diabetes

J Yoon, D Jung, Y Lee, B Park - Journal of personalized medicine, 2021 - mdpi.com
The metabolic score for insulin resistance (METS-IR) is a novel noninsulin-based marker for
assessing the risk of insulin resistance and cardiometabolic risk. However, whether METS …

Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: a …

SJ Han, KH Ha, N Lee, DJ Kim - Diabetes, Obesity and …, 2021 - Wiley Online Library
Aim To examine the real‐world cardiovascular effectiveness and safety associated with
sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor compared with dipeptidyl peptidase‐4 …

[HTML][HTML] Response: the risk of diabetes on clinical outcomes in patients with coronavirus disease 2019: a retrospective cohort study (Diabetes Metab J 2020; 44: 405 …

SM Chung, JH Ahn, JS Moon - Diabetes & metabolism …, 2020 - synapse.koreamed.org
We appreciate Dr. Kim and Professor Kim for their interest and comments on our article
entitled “The risk of diabetes on clinical outcomes in patients with coronavirus disease 2019 …

[HTML][HTML] Fibrates revisited: potential role in cardiovascular risk reduction

NH Kim, SG Kim - Diabetes & Metabolism Journal, 2020 - synapse.koreamed.org
Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying
drugs. Their main effects are reduction of triglycerides and increase in high-density …